Blog, News and Events

We are revolutionizing the translational potential of animal models in preclinical research. Discover the latest articles and news about our recent activities.

Exhibition at the EuroTox 2024

The Congress of the European Societies of Toxicology is organizing EuroTox 2024 to focus on this year's theme “Toxicology – A Quest for safe Chemicals and Medicines”. The program features a variety of topics dealing with safety of drugs and environmental chemicals, new and emerging technologies, personalized medicine, human health effects caused by exposure to chemicals as well as safety issues arising from climate changes. PhoenixBio is excited to be sponsoring a booth and attending the EuroTox 2024 in person at the Tivoli Congress Center in Copenhagen, Denmark on September 8th - 11th, 2024. Meet with our team at Booth #8 to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s technologies.

Topics icon Events

EuroTox 2024

Exhibition at the MPS World Summit 2024

The Microphysiological systems (MPS) World Summit presents the latest scientific achievements, discuss the advances and challenges, and enable communication between young and newly interested scientists and pioneers of the MPS field. PhoenixBio is excited to be sponsoring a booth and attending the third annual MPS World Summit in person at the Seattle Convention Center Summit in Seattle, Washington on June 11th - 14th, 2024. Meet with our team at Booth #68 to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s technologies.

Topics icon Events

MPS 2024

Exhibition at the EASL Congress 2024

The European Association for the Study of the Liver (EASL) Congress 2024 presents a diverse scientific programme tailored to various specialties and levels of expertise in hepatology, including: metabolism, alcohol, toxicity; cirrhosis; liver tumors; viral hepatitis; general hepatology; and more! PhoenixBio is excited to be sponsoring a booth and attending the EASL Congress 2024 in person in Milan, Italy on June 5th - 8th, 2024. Meet with our team at Booth #O2 to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s technologies.

Topics icon Events

EASL 2024

Exhibition at the American Society of Cell & Gene Therapy 2024 Meeting

The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for researchers in gene and cell therapy. The meeting will cover a range of topics from cutting-edge studies in cell and gene therapy, viral hepatitis, liver toxicity, MASH/MAFLD, and more. PhoenixBio is excited to be sponsoring a booth and attending ASGCT's 27th Annual Meeting in person at the Baltimore Convention Center in Baltimore, MD on May 7th - 11th, 2024. Meet with our team at Booth #1917 to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s therapies.

Topics icon Events

PhoenixBio Sponsor ASGCT 2024

Newsweek Feature: Pioneering Drug Development with Human Liver Models

Breaking News: Revolutionizing Pharmaceutical Innovation with Japan’s PhoenixBio In the realm of pharmaceutical innovation, a new dawn arises with Japan's PhoenixBio leading the charge. With a groundbreaking article recently published, PhoenixBio introduces cutting-edge human liver models boasting an astonishing 90% and higher human hepatocyte composition, redefining drug testing worldwide while upholding the highest ethical standards.

Topics icon Press Releases, News

Newsweek article on PhoenixBio

American Association for the Study of Liver Diseases 2023 Meeting

Get ready to join the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease! The Liver Meeting will cover a range of topics from cutting-edge studies in viral hepatitis, liver toxicity, gene therapy/editing, MASH/MAFLD, and more. PhoenixBio is delighted to be attending The Liver Meeting in person at the Hynes Convention Center in Boston, MA on November 11th - 13th, 2023. Meet with our team at Booth #1002 to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s therapies.

Topics icon Events

AASLD 2023

Unlocking the Future of AAV-Based Gene Therapies

The promise of adeno-associated virus (AAV) vector-based gene therapies is undeniable. These therapies have already demonstrated potential in treating conditions like spinal muscular atrophy, retinal dystrophy, and hemophilia B, with the FDA approving three treatments as of early 2023. Yet, despite these successes, many promising therapies fail during clinical trials.

Topics icon News, Blog

Liver Gene Therapy

Sign-up to our newsletter for the latest news and information straight to your inbox